Sensyne Health PLC Change in Registered Office (1514G)

TIDMSENS

RNS Number : 1514G

Sensyne Health PLC

28 March 2022

Sensyne Health plc

("Sensyne" or the "Company")

Change in Registered Office

Oxford, U.K. - 28 March 2022: Sensyne Health plc (LSE:SENS) ("Sensyne" or the "Company") announces that the Company's registered office address has changed to John Eccles House,

Robert Robinson Avenue, Oxford Science Park, Oxford, OX4 4GP with immediate effect.

All other details remain the same including the Company's website (www.sensynehealth.com), and telephone number (+44 (0) 330 058 1845).

This announcement has been made in accordance with Rule 17 of the AIM Rules for Companies.

-ENDS-

Notes for editors:

About Sensyne Health : https://www.sensynehealth.com/

Sensyne Health plc (LSE: SENS) is a clinical artificial intelligence company operating a unique business model - a for-profit plc making a positive social impact, sharing the financial returns it makes with health systems. The company applies clinical AI in the healthcare and life science industries. In healthcare, Sensyne delivers remote patient monitoring and real-time decision-making systems for healthcare organisations and their patients. In life sciences, Sensyne analyses large complex anonymized data sets to help life sciences companies accelerate the development of new medicines.

Sensyne Health is listed on the AIM Market of the London Stock Exchange (SENS.L).

Contact details:

 
  Sensyne Health 
  Lord (Paul) Drayson PhD FREng, Chief Executive 
   Officer 
   Dr Richard Pye, Chief Financial Officer            +44 (0) 330 058 1845 
  Peel Hunt LLP (Nominated Adviser and Joint          + 44 (0) 20 7418 
   Broker)                                             8900 
  Dr Christopher Golden 
   James Steel 
  Liberum (Joint Broker) 
  Phil Walker                                        + 44 (0) 20 3100 
   William Hall                                       2000 
  Consilium Strategic Communications 
  Mary-Jane Elliott                                  +44 (0) 7780 600290 
   Jessica Hodgson 
   CSCSensynehealth@consilium-comms.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

CROBLGDXXSDDGDR

(END) Dow Jones Newswires

March 28, 2022 02:00 ET (06:00 GMT)

Sensyne Health (LSE:SENS)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024